Skip to main content
Erschienen in: Infection 6/2019

08.10.2019 | Original Paper

Active surveillance of antibiotic resistance patterns in urinary tract infections in primary care in Switzerland

verfasst von: Andreas Plate, Andreas Kronenberg, Martin Risch, Yolanda Mueller, Stefania Di Gangi, Thomas Rosemann, Oliver Senn

Erschienen in: Infection | Ausgabe 6/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Urinary tract infections (UTI) are one of the most common reasons for prescribing antibiotics in primary care. In Switzerland, the Swiss Center for Antibiotic Resistances (ANRESIS) provides resistance data by passive surveillance, which overestimates the true resistance rates. The aim of this study was to provide actual data of the antimicrobial resistance patterns in patients with UTI in Swiss primary care.

Methods

From June 2017 to August 2018, we conducted a cross-sectional study in 163 practices in Switzerland. We determined the resistance patterns of uropathogens in patients with a diagnosis of a lower UTI and analyzed risk factors for resistance. Patients with age < 18 years, pregnancy or a pyelonephritis were excluded.

Results

1352 patients (mean age 53.8, 94.9% female) were included in the study. 1210 cases (89.5%) were classified as uncomplicated UTI. Escherichia coli (E. coli) was the most frequent pathogen (74.6%). Susceptibility proportions of E. coli to ciprofloxacin (88.9%) and trimethoprim-sulfamethoxazol (TMP/SMX) (85.7%) were significantly higher than the proportions reported by ANRESIS. We found high susceptibility to the recommended first-line antibiotics nitrofurantoin (99.5%) and fosfomycin (99.4%). Increasing age, antimicrobial exposure and a recent travel history were independently associated with resistance.

Discussion

In this study, we report actual data on the resistance patterns of uropathogens in primary care in Switzerland. Escherichia coli showed low resistance rates to the recommended first-line antibiotics. Resistance to TMP/SMX was significantly lower than reported by ANRESIS, making TMP/SMX a suitable and cheap alternative for the empirical treatment.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am J Med. 2002;113:5s–13s.CrossRefPubMed Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am J Med. 2002;113:5s–13s.CrossRefPubMed
4.
Zurück zum Zitat Ikaheimo R, Siitonen A, Heiskanen T, Karkkainen U, Kuosmanen P, Lipponen P, et al. Recurrence of urinary tract infection in a primary care setting: analysis of a 1-year follow-up of 179 women. Clin Infect Dis. 1996;22:91–9.CrossRefPubMed Ikaheimo R, Siitonen A, Heiskanen T, Karkkainen U, Kuosmanen P, Lipponen P, et al. Recurrence of urinary tract infection in a primary care setting: analysis of a 1-year follow-up of 179 women. Clin Infect Dis. 1996;22:91–9.CrossRefPubMed
6.
Zurück zum Zitat Kronenberg A, Butikofer L, Odutayo A, Muhlemann K, da Costa BR, Battaglia M, et al. Symptomatic treatment of uncomplicated lower urinary tract infections in the ambulatory setting: randomised, double blind trial. BMJ (Clin Res ed). 2017;359:j4784. https://doi.org/10.1136/bmj.j4784.CrossRef Kronenberg A, Butikofer L, Odutayo A, Muhlemann K, da Costa BR, Battaglia M, et al. Symptomatic treatment of uncomplicated lower urinary tract infections in the ambulatory setting: randomised, double blind trial. BMJ (Clin Res ed). 2017;359:j4784. https://​doi.​org/​10.​1136/​bmj.​j4784.CrossRef
7.
Zurück zum Zitat Gupta K, Hooton TM, Naber KG, Wullt B, Colgan R, Miller LG, et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for microbiology and infectious diseases. Clin Infect Dis. 2011;52:e103–20. https://doi.org/10.1093/cid/ciq257.CrossRefPubMed Gupta K, Hooton TM, Naber KG, Wullt B, Colgan R, Miller LG, et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for microbiology and infectious diseases. Clin Infect Dis. 2011;52:e103–20. https://​doi.​org/​10.​1093/​cid/​ciq257.CrossRefPubMed
8.
Zurück zum Zitat Hasse B, Egger M, Zanetti G, Marschall J, Mühlemann K, Harbarth S. Behandlung von unkomplizierten Harnwegsinfektionen. 2014. Hasse B, Egger M, Zanetti G, Marschall J, Mühlemann K, Harbarth S. Behandlung von unkomplizierten Harnwegsinfektionen. 2014.
17.
Zurück zum Zitat ECDC. Surveillance of antimicrobial resistance in Europe 2017. Annual report of the European Antimicrobial Resistance Surveillance Network (EARS-Net) 2017. ECDC. Surveillance of antimicrobial resistance in Europe 2017. Annual report of the European Antimicrobial Resistance Surveillance Network (EARS-Net) 2017.
21.
Zurück zum Zitat Almomani BA, Hayajneh WA, Ayoub AM, Ababneh MA, Al Momani MA. Clinical patterns, epidemiology and risk factors of community-acquired urinary tract infection caused by extended-spectrum beta-lactamase producers: a prospective hospital case–control study. Infection. 2018;46:495–501. https://doi.org/10.1007/s15010-018-1148-y.CrossRefPubMed Almomani BA, Hayajneh WA, Ayoub AM, Ababneh MA, Al Momani MA. Clinical patterns, epidemiology and risk factors of community-acquired urinary tract infection caused by extended-spectrum beta-lactamase producers: a prospective hospital case–control study. Infection. 2018;46:495–501. https://​doi.​org/​10.​1007/​s15010-018-1148-y.CrossRefPubMed
22.
Zurück zum Zitat Bonkat G, Bruyère F, Cai T, Geerlings SE, Köves B, Schubert S, Wagenlehner F. Urological infections guidelines 2018. Bonkat G, Bruyère F, Cai T, Geerlings SE, Köves B, Schubert S, Wagenlehner F. Urological infections guidelines 2018.
27.
Zurück zum Zitat Garau J, Xercavins M, Rodriguez-Carballeira M, Gomez-Vera JR, Coll I, Vidal D, et al. Emergence and dissemination of quinolone-resistant Escherichia coli in the community. Antimicrob Agents Chemother. 1999;43:2736–41.CrossRefPubMedPubMedCentral Garau J, Xercavins M, Rodriguez-Carballeira M, Gomez-Vera JR, Coll I, Vidal D, et al. Emergence and dissemination of quinolone-resistant Escherichia coli in the community. Antimicrob Agents Chemother. 1999;43:2736–41.CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Huttner A, Kowalczyk A, Turjeman A, Babich T, Brossier C, Eliakim-Raz N, et al. Effect of 5-day nitrofurantoin vs single-dose fosfomycin on clinical resolution of uncomplicated lower urinary tract infection in women: a randomized clinical trial. Effect of nitrofurantoin vs fosfomycin on uncomplicated lower UTI in women. Effect of nitrofurantoin vs fosfomycin on uncomplicated lower UTI in women. JAMA. 2018;319:1781–9. https://doi.org/10.1001/jama.2018.3627.CrossRefPubMedPubMedCentral Huttner A, Kowalczyk A, Turjeman A, Babich T, Brossier C, Eliakim-Raz N, et al. Effect of 5-day nitrofurantoin vs single-dose fosfomycin on clinical resolution of uncomplicated lower urinary tract infection in women: a randomized clinical trial. Effect of nitrofurantoin vs fosfomycin on uncomplicated lower UTI in women. Effect of nitrofurantoin vs fosfomycin on uncomplicated lower UTI in women. JAMA. 2018;319:1781–9. https://​doi.​org/​10.​1001/​jama.​2018.​3627.CrossRefPubMedPubMedCentral
Metadaten
Titel
Active surveillance of antibiotic resistance patterns in urinary tract infections in primary care in Switzerland
verfasst von
Andreas Plate
Andreas Kronenberg
Martin Risch
Yolanda Mueller
Stefania Di Gangi
Thomas Rosemann
Oliver Senn
Publikationsdatum
08.10.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
Infection / Ausgabe 6/2019
Print ISSN: 0300-8126
Elektronische ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-019-01361-y

Weitere Artikel der Ausgabe 6/2019

Infection 6/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.